Developments in Ovarian Cancer Treatment — Sloan-Kettering
Dr. Carol Aghajanian, Chief of Gynecologic Medical Oncology at Memorial Sloan-Kettering Cancer Center, discusses several new therapies she and her colleagues are developing to enhance the effectiveness of chemotherapy for ovarian cancer. These novel approaches target a variety of biological and genetic factors that contribute to the disease. For more information, please visit www.mskcc.org